Clinical Trials · NCT07487103
Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Enrollment
- 478
- Start date
- May 2026
- Locations
- See registry
- Primary endpoint
- Change in HbA1c